Medigene Revenue vs. Price To Earning

MDGEFDelisted Stock  USD 2.59  0.00  0.00%   
Based on the measurements of profitability obtained from Medigene's financial statements, Medigene AG may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Medigene's ability to earn profits and add value for shareholders.
For Medigene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medigene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medigene AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medigene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medigene AG over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Please note, there is a significant difference between Medigene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medigene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medigene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medigene AG Price To Earning vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Medigene's current stock value. Our valuation model uses many indicators to compare Medigene value to that of its competitors to determine the firm's financial worth.
Medigene AG is regarded second in revenue category among its peers. It is considered to be number one stock in price to earning category among its peers . The ratio of Revenue to Price To Earning for Medigene AG is about  1,989,164 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medigene's earnings, one of the primary drivers of an investment's value.

Medigene Revenue vs. Competition

Medigene AG is regarded second in revenue category among its peers. Market size based on revenue of Biotechnology industry is now estimated at about 96.72 Million. Medigene retains roughly 10.46 Million in revenue claiming about 11% of stocks in Biotechnology industry.

Medigene Price To Earning vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Medigene

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
10.46 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Medigene

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
5.26 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Medigene Price To Earning Comparison

Medigene is currently under evaluation in price to earning category among its peers.

Medigene Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Medigene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medigene will eventually generate negative long term returns. The profitability progress is the general direction of Medigene's change in net profit over the period of time. It can combine multiple indicators of Medigene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company was founded in 1994 and is headquartered in Munich, Germany. Medigene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 61 people.

Medigene Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Medigene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medigene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medigene's important profitability drivers and their relationship over time.

Use Medigene in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigene will appreciate offsetting losses from the drop in the long position's value.

Medigene Pair Trading

Medigene AG Pair Trading Analysis

The ability to find closely correlated positions to Medigene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigene AG to buy it.
The correlation of Medigene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigene AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Medigene position

In addition to having Medigene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipbuilding Railroad Equipment Thematic Idea Now

Shipbuilding Railroad Equipment
Shipbuilding Railroad Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Medigene Pink Sheet

If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk